NexgenRx Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was CAD 3.17 million compared to CAD 2.8 million a year ago. Net income was CAD 0.377956 million compared to CAD 0.362111 million a year ago. Basic earnings per share from continuing operations was CAD 0.005 compared to CAD 0.005 a year ago. Diluted earnings per share from continuing operations was CAD 0.005 compared to CAD 0.005 a year ago.